Home Cart Sign in  
Chemical Structure| 92-61-5 Chemical Structure| 92-61-5

Structure of Scopoletin
CAS No.: 92-61-5

Chemical Structure| 92-61-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Scopoletin has important anti-inflammatory activity by inhibiting the phosphorylation of NF-κB and p38 MAPK.

Synonyms: Gelseminic acid; Chrysatropic acid; NSC 405647

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Scopoletin

CAS No. :92-61-5
Formula : C10H8O4
M.W : 192.17
SMILES Code : COC1=C(O)C=C2OC(=O)C=CC2=C1
Synonyms :
Gelseminic acid; Chrysatropic acid; NSC 405647
MDL No. :MFCD00006872
InChI Key :RODXRVNMMDRFIK-UHFFFAOYSA-N
Pubchem ID :5280460

Safety of Scopoletin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Scopoletin

RTK
MAPK
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
CCRF-CEM 26.1 µM (IC50) 72 hours Evaluate the cytotoxicity of Scopoletin on CCRF-CEM cells Molecules. 2016 Apr 15;21(4):496
SCN second-stage juveniles (J2) 81.00 µg/mL, 40.50 µg/mL, 20.25 µg/mL, 4.05 µg/mL, 0.81 µg/mL 12, 24, 48, 72, and 96 hours Evaluate the nematicidal activity of Scopoletin against SCN J2. High concentrations of Scopoletin (T1 and T2) showed significant effects on J2 poisoning, while lower concentrations (T4 and T5) had negligible effects. Life (Basel). 2021 Oct 26;11(11):1143
HeLa cells 250 µM 15 minutes To test the antioxidant capacity of Sp under oxidative stress conditions, results showed that Sp significantly reduced 3-AT-induced oxidative radicals and improved cell viability. Cell Death Dis. 2020 Sep 10;11(9):739
Horseradish peroxidase (HRP) 1 µM 150 msec to 5 sec Scopoletin rapidly reacts with HRP to form a stable, spectroscopically distinguishable form of the enzyme, inhibiting HRP's reactions with molecular oxygen and indole-3-acetic acid (IAA). Plant Physiol. 1972 Jun;49(6):1012-8
Phakopsora pachyrhizi uredospores 500 µM 16 hours Scopoletin inhibited the germination of Pp spores, and this inhibition was reversible. Plant J. 2019 Aug;99(3):397-413
Bone marrow-derived dendritic cells (BM-DCs) 100 µM 18 hours Scopoletin significantly inhibited the activation of BM-DCs, reducing the expression of MHC II, CD80, and CD86. Front Pharmacol. 2019 Aug 2;10:863
Rheumatoid arthritis fibroblast-like synoviocytes (HFLS-RA) 20 µM 24 and 48 hours To evaluate the inhibitory effect of Scopoletin on HFLS-RA cell migration. Results showed that Scopoletin significantly reduced single-cell migration but only slightly inhibited collective migration. Front Pharmacol. 2022 Jul 25;13:946210
Rheumatoid arthritis fibroblast-like synoviocytes (HFLS-RA) 20 µM 24 and 48 hours To evaluate the inhibitory effect of Scopoletin on HFLS-RA cell proliferation. Results showed that Scopoletin significantly inhibited HFLS-RA proliferation at 30 μM and onwards. Front Pharmacol. 2022 Jul 25;13:946210
Rat insulinoma 5f (RIN5f) cells 100 µM 24 hours To evaluate the protective effect of SPL on palmitate-induced ER stress. SPL reduced the phosphorylation levels of IRE1α, PERK, and ATF6α induced by palmitate, indicating that SPL effectively inhibited ER stress in RIN5f cells. Cell Stress Chaperones. 2018 Sep;23(5):857-869
SHSY-5Y cells 250 µM 24 hours To evaluate the protective effects of Sp against MPP+-induced mitochondrial dysfunction and oxidative stress, results showed that Sp restored mitochondrial function and reduced oxidative stress. Cell Death Dis. 2020 Sep 10;11(9):739
HEK 293 cells 2 mM 24 hours Luciferase reporter assay confirmed Scopoletin activates HIV-1 LTR via NF-κB pathway Int J Mol Sci. 2023 Aug 10;24(16):12649
Spodoptera frugiperda Sf9 cells 0, 10, 50, 90 µM 24 hours To investigate the effect of scopoletin on intracellular free calcium [Ca2+]i levels in Sf9 cells. Results showed that scopoletin significantly elevated the [Ca2+]i levels in a concentration-dependent manner. Front Physiol. 2019 Mar 6;10:164
Rheumatoid arthritis fibroblast-like synoviocytes (HFLS-RA) 20 µM 24 hours To evaluate the inhibitory effect of Scopoletin on HFLS-RA cell invasion. Results showed that Scopoletin reduced the number of invasive cells, but the inhibitory rate was approximately half that of umbelliferone. Front Pharmacol. 2022 Jul 25;13:946210
FL83B hepatocytes 5 µM–25 µM (IC50) 24 hours To investigate the effects of scopoletin on MG-induced insulin resistance, results showed that scopoletin promoted Akt phosphorylation, restored PPARγ expression, suppressed PTP1B expression, and promoted GLUT2 plasma translocation. Molecules. 2015 Feb 9;20(2):2786-801
SH-SY5Y cells 5 µM 3 hours pretreatment followed by 24 hours exposure to H2O2 To evaluate the neuroprotective effects of scopoletin against H2O2-induced neuronal cell death. Results showed that scopoletin pretreatment significantly increased cell viability (95.1±4.7%), reduced apoptotic cell count (13.3±1.2%) and ROS levels (100.0±1.4%), and maintained the expression levels of SIRT1, FoxO3a, ADAM10, BCL-2, and antioxidant enzymes (catalase and SOD2). RSC Adv. 2020 Apr 27;10(28):16593-16606
Candida tropicalis ATCC 28707 50 mg/mL 48 hours To evaluate the antifungal activity of scopoletin against a multidrug-resistant Candida tropicalis strain. Results showed scopoletin has a fungistatic effect, significantly reducing fungal growth curves and cell density (91.7% reduction). Front Microbiol. 2020 Jul 7;11:1525
Raw 264.7 cells 1–20 µM 5 days Scopoletin promoted the formation of TRAP-positive multinucleated osteoclasts and bone resorption, reversing the impairment of osteoclast differentiation by high glucose Biomedicines. 2021 Jun 7;9(6):648
Alternaria alternata 48, 96, 240, 480 μg ml–1 6 days To test the inhibitory effect of Scopoletin on the growth of Alternaria alternata. Results showed that Scopoletin significantly inhibited fungal growth, with higher concentrations showing stronger inhibition. J Exp Bot. 2014 Aug;65(15):4305-15
MC3T3-E1 cells 1–20 µM 7 days Scopoletin enhanced ALP activity and mineralized bone nodule deposition, ameliorating the impairment of osteoblast differentiation by high glucose Biomedicines. 2021 Jun 7;9(6):648
Jurkat T cells (C11 cell line) 0.25-2.0 mM 72 hours Scopoletin reactivated latent HIV-1 transcription in a time-dependent manner, with GFP+ cells increasing from 8.02% to 42.65% Int J Mol Sci. 2023 Aug 10;24(16):12649
Jurkat T cells (A10.6 cell line) 0.2-1.6 mM 72 hours Scopoletin reactivated latent HIV-1 transcription in a dose-dependent manner, with GFP+ cells increasing from 10.72% to 28.87% Int J Mol Sci. 2023 Aug 10;24(16):12649
CEM/ADR5000 37.5 µM (IC50) 72 hours Evaluate the cytotoxicity of Scopoletin on CEM/ADR5000 cells Molecules. 2016 Apr 15;21(4):496
CEM/ADR5000 37.5 ± 2.9 µM (IC50) 72 hours Evaluate the cytotoxicity of Scopoletin on CEM/ADR5000 cells Molecules. 2016 Apr 15;21(4):496
CCRF-CEM 26.1 ± 1.6 µM (IC50) 72 hours Evaluate the cytotoxicity of Scopoletin on CCRF-CEM cells Molecules. 2016 Apr 15;21(4):496

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Tetranychus cinnabarinus (carmine spider mite) Adult female mites Dip method 0.938 mg/mL (LC50) 48 hours To evaluate the acaricidal toxicity of scopoletin against T. cinnabarinus. Results showed that scopoletin exhibited significant acaricidal activity with an LC50 value of 0.938 mg/mL. Front Physiol. 2019 Mar 6;10:164
Male mice DSS-induced colitis model Oral 1 mg/kg, 1.5 mg/kg, 2 mg/kg Once daily, starting 14 days prior to and during DSS treatment Scopoletin significantly improved DSS-induced colitis symptoms, including reduced weight loss and colonic shortening, decreased levels of TNF-α, IL-1β, and IL-12 cytokines, attenuated NLRP3 inflammasome activation, and modulated the immune response by elevating PPARγ expression and suppressing NF-κB pathway activation. Additionally, scopoletin altered gut microbiota composition by increasing beneficial Lactobacillus and Bifidobacteria and reducing E. coli, and enhanced tight junction proteins, indicating improved intestinal barrier integrity. Inflammation. 2025 Apr;48(2):575-589
Sprague Dawley rats High-fat, high-fructose diet (HFFD)-fed rats Oral 1 mg/kg/day Once daily for 45 days To evaluate the effect of SPL on HFFD-induced pancreatic ER stress. SPL reduced the phosphorylation levels of IRE1α, PERK, and ATF6α induced by HFFD and inhibited the phosphorylation of JNK, indicating that SPL effectively alleviated pancreatic ER stress. Cell Stress Chaperones. 2018 Sep;23(5):857-869
Db/db mice Type 2 diabetes model Oral 10 mg/kg Once daily for 10 weeks Scopoletin inhibited bone loss by enhancing the induction of bone turnover markers, increasing bone mineral density and content Biomedicines. 2021 Jun 7;9(6):648
Wistar rats MG-induced diabetic model Oral administration 10 mg/kg Once daily for 12 weeks To investigate the protective effects of scopoletin against MG-induced hyperglycemia and insulin resistance, results showed that scopoletin improved OGTT results, reduced fasting blood glucose, restored C-peptide levels, ameliorated dyslipidemia, and promoted MG metabolism into D-lactic acid by activating Nrf2, thereby inhibiting AGEs generation. Molecules. 2015 Feb 9;20(2):2786-801
Sprague-Dawley rats Healthy rats Oral 100 mg/kg Single dose Evaluate pharmacokinetics and biodistribution of Sco-Ms Acta Pharmacol Sin. 2017 Mar;38(3):424-433
Zebrafish embryos Zebrafish embryo developmental toxicity model Aqueous solution exposure 18.5 µg/mL Exposure solution changed daily until 120 hpf Evaluated the metabolic effects of Scopoletin on zebrafish embryos, revealing significant metabolic disturbances Metabolites. 2022 Oct 1;12(10):934
C57BL/6 mice Complete Freund’s adjuvant (CFA)-induced chronic inflammation anxiety model Intraperitoneal injection 2.0, 10.0, 50.0 mg/kg Once daily for 14 consecutive days SP dose-dependently ameliorated CFA-induced anxiety-like behaviors, inhibited microglia activation, decreased peripheral and central IL-1β, IL-6, and TNF-α levels, and modulated the imbalance of excitatory/inhibitory receptors and neurotransmitters Mol Brain. 2020 Feb 4;13(1):15
Drosophila melanogaster Park13 mutant flies Oral administration 2.5 mM Continuous treatment starting from 10 days AEL To assess the neuroprotective effects of Sp in a Parkinson's disease model, results showed that Sp improved the survivability of dopaminergic neurons, reduced oxidative stress, and restored motor abilities. Cell Death Dis. 2020 Sep 10;11(9):739
BALB/c nude mice HepG2 xenograft model Intraperitoneal injection 2.5, 5, 10 mg/kg Once daily for 14 days SC-III3 significantly inhibited tumor growth with inhibition rates of 31.2%, 38.6%, and 52.4% BMC Cancer. 2014 Dec 19;14:987
Korean native chickens High stocking density stress model Dietary supplementation 20 mg/kg diet Once daily for 35 days To investigate the effects of Scopoletin on growth performance, antioxidant activity, and meat quality of chickens under high stocking density stress. Results showed that Scopoletin supplementation decreased MDA concentration in serum and leg muscle, increased catalase, superoxide dismutase, and total antioxidant capacity, and improved meat quality and growth performance. Foods. 2021 Jun 29;10(7):1505
C57BL/6 mice Experimental autoimmune encephalomyelitis (EAE) model Intraperitoneal injection 50 mg/kg Once daily for 20 days Scopoletin significantly ameliorated the severity of EAE, reduced inflammation and demyelination in the CNS, and inhibited DC activation and Th1/Th17 cell polarization. Front Pharmacol. 2019 Aug 2;10:863
Soybean (Glycine max) Asian soybean rust model Foliar spray 500 μM Single treatment Scopoletin protected soybean from SBR by directly inhibiting Pp development rather than activating the plant defense system. Plant J. 2019 Aug;99(3):397-413
Soybean (Glycine max) Soybean cyst nematode (Heterodera glycines) infection model Seed coating 70:1 (w:v) seed coating Field experiments in 2017 and 2018 Evaluate the biocontrol effect of Scopoletin against soybean cyst nematode. Scopoletin treatment significantly reduced nematode numbers in roots and soil, and promoted soybean growth and yield. Life (Basel). 2021 Oct 26;11(11):1143
Rats Healthy rats Intravenous and oral Intravenous 5 mg/kg; oral 5, 10, and 20 mg/kg Single dose To study the pharmacokinetics and oral bioavailability of Scopoletin in rats. The results showed that the oral bioavailability was 6.62% ± 1.72% for 5 mg/kg, 5.59% ± 1.16% for 10 mg/kg, and 5.65% ± 0.75% for 20 mg/kg. Molecules. 2015 Oct 19;20(10):18988-9001

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.20mL

1.04mL

0.52mL

26.02mL

5.20mL

2.60mL

52.04mL

10.41mL

5.20mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories